Deconvolution of pro- and anti-viral responses to Dengue virus and Zika Virus infections
Deconvolution of pro- and anti-viral responses to Dengue virus and Zika Virus infections
批准号:
10319989
负责人:
Aaron F. Carlin
金额:
$20.38万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-01-01 至 2023-12-31
关键词:
Antiviral ResponseBindingCellsChIP-seqChromatinClinicalClinical Investigator AwardComplexDNADNA Binding DomainDataData SetDengue InfectionDengue VirusDiseaseEnhancersEpigenetic ProcessFamilyFamily memberFlavivirusGene ActivationGene ExpressionGene Expression ProfileGenesGeneticGenetic TranscriptionGenomeGenomicsHumanIRF1 geneIRF3 geneImmune responseIn VitroIndividualInfectionInterferon ActivationInterferon Type IIInterferonsKnockout MiceLifeMeasuresMethodsModelingMusNeuraxisPathogenesisPathologyPersonsPharmaceutical PreparationsPlayPopulationPredispositionRegulationResearchResearch PersonnelRiskRoleSignal TransductionSystemTestingTimeTrainingTranscriptional RegulationTranslatingVaccinesViralVirulenceVirusVirus DiseasesWorkZIKV diseaseZIKV infectionZika Virusactivating transcription factorcareerexperienceexperimental studygenome-widein vivoinsightmacrophagemembermonocytemortalityneuropathologypathogenpreventprogramsreceptorresponsetranscription factortranscriptome sequencingtranscriptomicsviral interferon regulatory factor
中文摘要
项目摘要/摘要:
干扰素调节因子(IRFs)家族转录因子是抗病毒的中枢调节因子
回应。它们将病原体识别受体的信号翻译成复杂的转录
对病毒控制至关重要的反应。IRF转录因子在小鼠体内的靶向性基因缺失增加
对病毒的易感性,进而进化出使IRF信号失活的机制,从而导致
毒力增强。尽管它们很重要,但我们仍然不了解红外线如何协调对
转录以保护我们免受病毒侵袭。IRF转录因子在它们的DNA结合域和
结合高度相似的DNA基序。然而,它们调节非冗余的抗病毒转录程序。这个
这项建议的总体目标是确定抗病毒IRF转录因子如何作用于特定基因和基因组
控制抗病毒反应的广泛范围。特定目标1中的实验将调查为什么DENV,以及
而不是ZIKV,似乎能刺激IRF-1和干扰素γ反应。其他研究将测试是否缺乏干扰素γ
反应可以帮助解释ZIKV的神经病理。在特定目标2中的研究将确定全基因组网络
在DENV和ZIKV感染期间IRF基因激活和转录特征的研究。比较
被感染和未被感染的邻近细胞的反应将识别宿主细胞信号的病毒颠覆。
此外,比较DENV和ZIKV感染细胞的反应将识别病毒特异性激活
依赖IRF的反应。最后,全基因组信号依赖和谱系决定转铁蛋白的整合
活性增强剂的结合和基因组特征将有助于建立支配红外线受体如何
相互协作和其他转录因子建立功能增强子和控制基因表达。
这项提案将共同确定管理IRF对病毒反应的调控的基本原则,并确定
病毒特异性IRF反应的差异可能解释疾病的发病机制和先进的治疗
这些目前无法治愈的感染。
英文摘要
Project Summary/Abstract:
The interferon-regulatory factor (IRFs) family of transcription factors (TFs) are central regulators of anti-viral
responses. They translate signals from pathogen recognition receptors into complex transcriptional
responses that are essential for viral control. Targeted genetic deletion of IRF TFs in mice increase
susceptibility to viruses, which in turn have evolved mechanism to deactivate IRF signaling leading to
increased virulence. Despite their importance, we still do not understand how IRFs coordinate the control of
transcription to protect us from viruses. IRF TFs share structural homology in their DNA binding domains and
bind highly similar DNA motifs. Yet, they regulate non-redundant antiviral transcriptional programs. The
overall objective of this proposal is to determine how anti-viral IRF TFs act on a gene specific and genome
wide scale to control anti-viral responses. The experiments in specific aim 1 will investigate why DENV, and
not ZIKV, appears to stimulate IRF-1 and IFNγ responses. Additional studies will test if the lack of IFNγ
response can help explain ZIKV neuropathology. Studies in specific Aim 2 will identify genome-wide networks
of IRF gene activation and transcriptional signatures during DENV and ZIKV infections. Comparisons of
responses in infected and uninfected neighboring cells will identify viral subversion of host cell signaling.
Additionally, comparing responses in DENV and ZIKV infected cells will identify viral specific activation of
IRF-dependent responses. Lastly, integration of genome-wide signal dependent and lineage determining TF
binding and genomic features of active enhancers will help establish basic principals governing how IRFs
cooperate with each other and other TFs to establish functional enhancers and control gene expression.
Together this proposal will identify basic principals governing IRF regulation of viral responses and identify
differences in viral specific IRF responses that may explain disease pathogenesis and advance treatments for
these currently untreatable infections.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deconvolution of pro- and anti-viral responses to Dengue virus and Zika Virus infections
-
批准号:10530616
-
项目类别:
-
资助金额:$20.38万
-
财政年份:2019
-
负责人:Aaron F. Carlin
-
依托单位:
Deconvolution of pro- and anti-viral responses to Dengue virus and Zika Virus infections
-
批准号:10082422
-
项目类别:
-
资助金额:$20.38万
-
财政年份:2019
-
负责人:Aaron F. Carlin
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: